Lumida
/CSTL
⌘K
Castle Biosciences Inc

Castle Biosciences Inc

CSTL
$32.32USD↑+0.03%+0.01 today

MARKET CAP

987.4M

P/E (TTM)

—

FWD P/E

—

DAY RANGE

$31 – $33

52W RANGE

$18
$44

AI Summary

Stalk
StalkMedium

CSTL remains in a Stage 2 advancing regime with a bullish medium-term bias. The recent pullback into rising EMAs on declining volume is healthy within the uptrend, but short-term momentum has cooled near overbought levels. We will defer engagement and monitor for clear acceptance off the 9/20-EMA support zone before initiating exposure.

  • ↑Q2 revenue reached $103.5M, +20% YoY driven by core tests
  • ↑TissueCypher volumes rose 63% YoY to 14,988 reports
  • ↓Net loss of $2.1M in Q2 2026 amid rising SG&A costs
Full analysis →

Buying

7

institutions

Selling

5

institutions

New Positions

1

this quarter

Filing Period

Q2 2026

latest 13-F

13-F Holdings

Institution↕Action↕Shares Held↕Value↓Change↕Chg %↕Weight↕
BI

Blackrock, Inc.

Q2 2026

BUY3.29 M78.51 M+309.02 K+7.2%0.00%
RI

Rtw Investments, LP

Q2 2026

BUY2.78 M66.26 M+20.00 K-2.1%0.57%
RT

Renaissance Technologies LLC

Q2 2026

SELL371.20 K8.85 M+-161.60 K-32.3%0.01%
PA

Point72 Asset Management, L.P.

Q2 2026

BUYNEW357.32 K8.52 M+357.32 K+0.0%0.01%
CA

Citadel Advisors LLC

Q2 2026

BUY265.35 K6.33 M+99.38 K+55.3%0.00%
MM

Millennium Management LLC

Q2 2026

SELL205.37 K4.90 M+-147.95 K-43.5%0.00%
AC

Aqr Capital Management LLC

Q2 2026

BUY166.57 K3.97 M+101.69 K+149.4%0.00%
MG

Man Group Plc

Q2 2026

BUY108.76 K2.59 M+61.62 K+124.2%0.00%
JC

Jpmorgan Chase & Co

Q2 2026

SELL84.80 K2.06 M+-3.97 K-1.4%0.00%
JH

Janus Henderson Group Plc

Q1 2026

BUY30.07 K738.17 K+15.04 K+26.2%0.00%
RC

Rockefeller Capital Management L.P.

Q2 2026

SELL87.002.08 K+-346.00-80.5%0.00%
BH

Brevan Howard Capital Management LP

Q2 2026

SELL0.000.00+-18.56 K-100.0%0.00%